找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Handbook of HER2-Targeted Agents in Breast Cancer; Ricardo H Alvarez,Javier Cortés,Martine Piccart Book 2016Latest edition Springer Intern

[復(fù)制鏈接]
樓主: 呻吟
21#
發(fā)表于 2025-3-25 03:19:49 | 只看該作者
https://doi.org/10.1007/978-3-319-28216-9Breast cancer; Cancer; HER2; HER2-positive; Oncology; Pertuzumab; Trastuzumab; Diagnostic Radiology
22#
發(fā)表于 2025-3-25 10:26:58 | 只看該作者
23#
發(fā)表于 2025-3-25 14:11:33 | 只看該作者
Leticia De Mattos-Arruda,Javier Cortésenges for operators and service providers. On one hand, the shift toward microservice-based network functions (NFs) provides greater scalability and reliability advantages; however, on the other hand, it is expensive to realize and very complex to manage and test.
24#
發(fā)表于 2025-3-25 17:24:04 | 只看該作者
Dimitrios Zardavas,Martine Piccarte a dark object in the scene, it looks very artificial; conversely, the same can be said for placing a very light object in a dark environment. So where possible we want to take the real-world lighting conditions into consideration in our scene.
25#
發(fā)表于 2025-3-25 22:39:37 | 只看該作者
Introduction and background biology,ent in this chapter of modern pharmacology is the outstanding results obtained from targeting the receptor tyrosine kinase (RTK) coded by the . gene (also known as human epidermal growth factor receptor 2 [HER2]) with the humanized monoclonal antibody trastuzumab in women with HER2 overexpressing/amplified breast cancer.
26#
發(fā)表于 2025-3-26 03:19:32 | 只看該作者
HER2-positive metastatic breast cancer: second-line treatment,ancers, primarily due to gene amplification [1]. Over the last 15 years, several HER2-targeted therapies have been developed and have significantly improved the outcome of patients with metastatic breast cancer (MBC).
27#
發(fā)表于 2025-3-26 04:26:45 | 只看該作者
Emerging targeted agents for HER2-positive breast cancer,elopment of HER2-targeted agents. Trastuzumab represents the archetype of molecular-targeted agents in the setting of solid tumors, with efficacy proven in metastatic, neoadjuvant, and adjuvant settings of HER2-positive breast cancer
28#
發(fā)表于 2025-3-26 10:36:31 | 只看該作者
Book 2016Latest editiont understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.
29#
發(fā)表于 2025-3-26 13:24:39 | 只看該作者
30#
發(fā)表于 2025-3-26 18:19:16 | 只看該作者
Nadia HarbeckIn this chapter, you will learn tips on the basics of security, including the governing principles, control frameworks, threats, risks, and legal issues concerning security. Understand these concepts as they apply in day-to-day work of a cybersecurity professional.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 00:12
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
嘉义市| 永春县| 深州市| 太和县| 长岛县| 德安县| 五寨县| 盐山县| 洞口县| 禹州市| 瓦房店市| 白玉县| 漳州市| 得荣县| 密云县| 东山县| 犍为县| 昌黎县| 兴国县| 罗山县| 临洮县| 台州市| 会同县| 洱源县| 长春市| 磴口县| 永春县| 富裕县| 梁山县| 信丰县| 辽阳市| 宁都县| 凤城市| 和林格尔县| 永仁县| 渝中区| 易门县| 临沭县| 宜黄县| 科技| 思茅市|